| Literature DB >> 26070527 |
Miriam Granado1, Sara Amor1, Juan José Montoya2, Luis Monge1, Nuria Fernández1, Ángel Luis García-Villalón3.
Abstract
The aim of this study is to analyze the expression of purinergic receptors in the heart after ischemia-reperfusion, and their possible role in ischemia-reperfusion injury. Rat hearts were perfused according to the Langendorff technique and subjected to 30 min ischemia followed by 15 min reperfusion. Ischemia-reperfusion reduced the gene expression and protein content of purinergic receptors of the P2Y2 subtype, and increased the gene expression and protein content of the P2X7 subtype. Treatment with the agonist of the P2Y2 subtype 2-thio-UTP and with the antagonist of the P2X7 subtype Brilliant Blue improved myocardial function parameters, reduced cell death and increased the myocardial expression of antiapoptotic markers after ischemia-reperfusion. These results suggest that the myocardial expression of the protective P2Y2 subtype of purinergic receptors is reduced, whereas that of the harmful subtype P2X7 subtype is increased during coronary ischemia-reperfusion. This may contribute to myocardial injury in this condition.Entities:
Keywords: Ischemia–reperfusion; Langendorff; P2Y2, P2X7; Purinergic receptors
Mesh:
Substances:
Year: 2015 PMID: 26070527 DOI: 10.1016/j.vph.2015.06.003
Source DB: PubMed Journal: Vascul Pharmacol ISSN: 1537-1891 Impact factor: 5.773